What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Major depressive disorder
- Psychiatry
His primary areas of study are Psychiatry, Internal medicine, Depression, Major depressive disorder and Placebo.
Richard C. Shelton has included themes like Case-control study and Pediatrics in his Psychiatry study.
His Internal medicine research incorporates themes from Venlafaxine and Endocrinology.
His studies deal with areas such as Functional magnetic resonance imaging and Clinical psychology as well as Depression.
His work carried out in the field of Major depressive disorder brings together such families of science as Antidepressant, Adverse effect, Clinical trial and Young adult.
The study incorporates disciplines such as Response rate and Mood in addition to Placebo.
His most cited work include:
- Antidepressant Drug Effects and Depression Severity: A Patient-Level Meta-analysis (1385 citations)
- Cognitive therapy vs medications in the treatment of moderate to severe depression. (756 citations)
- Prevention of relapse following cognitive therapy vs medications in moderate to severe depression. (553 citations)
What are the main themes of his work throughout his whole career to date?
The scientist’s investigation covers issues in Psychiatry, Internal medicine, Depression, Major depressive disorder and Placebo.
He interconnects Endocrinology and Rating scale in the investigation of issues within Internal medicine.
As a part of the same scientific family, Richard C. Shelton mostly works in the field of Depression, focusing on Clinical psychology and, on occasion, Psychotherapist.
In the field of Major depressive disorder, his study on Hamilton Rating Scale for Depression overlaps with subjects such as Pimavanserin.
His study in Placebo is interdisciplinary in nature, drawing from both Escitalopram, Anesthesia and Ziprasidone.
His research in Cognitive therapy tackles topics such as Cognitive behavioral therapy which are related to areas like Combined Modality Therapy.
He most often published in these fields:
- Psychiatry (46.18%)
- Internal medicine (45.04%)
- Depression (38.24%)
What were the highlights of his more recent work (between 2015-2021)?
- Internal medicine (45.04%)
- Depression (38.24%)
- Major depressive disorder (33.14%)
In recent papers he was focusing on the following fields of study:
His main research concerns Internal medicine, Depression, Major depressive disorder, Psychiatry and Randomized controlled trial.
His research integrates issues of Placebo, Endocrinology and Rating scale in his study of Internal medicine.
His Depression study incorporates themes from Body mass index and Ketamine.
In Major depressive disorder, Richard C. Shelton works on issues like Antidepressant, which are connected to Pharmacology and Cognitive therapy.
His study in the fields of Pharmacotherapy under the domain of Psychiatry overlaps with other disciplines such as Weight gain.
His Randomized controlled trial study deals with Number needed to treat intersecting with Combined Modality Therapy, Cognitive behavioral therapy and Psychological intervention.
Between 2015 and 2021, his most popular works were:
- Efficacy and Safety of Intranasal Esketamine Adjunctive to Oral Antidepressant Therapy in Treatment-Resistant Depression: A Randomized Clinical Trial (224 citations)
- A Double-Blind, Randomized, Placebo-Controlled, Dose-Frequency Study of Intravenous Ketamine in Patients With Treatment-Resistant Depression (220 citations)
- Efficacy and Safety of Flexibly Dosed Esketamine Nasal Spray Combined With a Newly Initiated Oral Antidepressant in Treatment-Resistant Depression: A Randomized Double-Blind Active-Controlled Study (131 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Major depressive disorder
- Gene
Richard C. Shelton mostly deals with Internal medicine, Major depressive disorder, Depression, Randomized controlled trial and Bipolar disorder.
Richard C. Shelton has researched Internal medicine in several fields, including Endocrinology and Mood disorders.
His Major depressive disorder study combines topics in areas such as Placebo-controlled study, microRNA, Reuptake inhibitor and Immunology.
Richard C. Shelton combines subjects such as Body mass index, Ketamine and Rating scale with his study of Depression.
The Randomized controlled trial study combines topics in areas such as Young adult, Relapse prevention and Placebo, Number needed to treat.
Quetiapine is a primary field of his research addressed under Psychiatry.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
